D Amp- M Pharma Peru S.a.c Fix Jun 2026

To understand the significance of D&M Pharma Peru S.A.C., one must first understand the structure of the Peruvian pharmaceutical market. The market is broadly divided into two channels: the (hospitals and establishments under the Ministry of Health, EsSalud, and the Armed Forces) and the private sector (pharmacy chains, private clinics, and independent pharmacies).

The “S.A.C.” designation indicates that the company is not publicly traded, allowing it to focus on long-term strategic goals rather than quarterly market pressures. The inclusion of “Pharma” in its name signals a dedicated focus on pharmaceutical products, medical devices, and related health solutions.

Some reports indicate that the company also collaborates with regional health authorities (Gobiernos Regionales) for public procurement tenders, supplying essential medicines to hospitals in Loreto, Cusco, and Puno. d amp- m pharma peru s.a.c

Focused on respiratory health, dermatology, and biotechnology.

A: It is primarily a distributor and importer. It does not manufacture APIs but packages and distributes finished pharmaceutical products under its quality oversight. To understand the significance of D&M Pharma Peru S

In the intricate web of the Peruvian healthcare system, represents the backbone of pharmaceutical accessibility. By ensuring that vital medications and

For pharmacies and patients wishing to confirm the legitimacy of products distributed by D Amp- M Pharma Peru S.A.C., the following steps are recommended: The inclusion of “Pharma” in its name signals

D & M Pharma Peru S.A.C.: Company Overview is a specialized pharmaceutical enterprise based in Lima, Peru, that focuses on the wholesale distribution of nondurable goods, specifically high-quality medications. Established as part of a regional expansion by Chilean executives, the company has become a key player in the Peruvian pharmaceutical landscape, particularly through its partnership with the Argentine firm Laboratorio Cassará . Company Profile and History

In , D&M Pharma launched its activities in Peru, officially incorporating as D & M Pharma Peru S.A.C. the following year. Today, the company operates with a team of approximately 32 employees out of its headquarters in the San Isidro district of Lima . Core Business Activities and Portfolio

Peru’s regulatory body, (General Directorate of Medicines, Supplies, and Drugs), enforces some of the strictest standards in Latin America regarding Good Storage and Distribution Practices (BPA). D&M Pharma must maintain rigorous quality control systems to ensure that every product meets the standards set by Peruvian Law (such as the Ley General de Salud and Decreto Legislativo N° 1310 ). This involves sophisticated warehousing, temperature monitoring, and traceability systems to guarantee product integrity.